Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nicholson Price

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Michigan Law Review|December 15, 2017
Regulating Black-Box MedicineW Nicholson Price
The American Journal of Bioethics : AJOB|February 9, 2013
Legal implications of an ethical duty to search for genetic incidental findingsW Nicholson Price
Science Translational Medicine|December 14, 2018
Big data and black-box medical algorithmsW Nicholson Price
Nature Biotechnology|July 9, 2015
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?W Nicholson Price, Timo Minssen
Science (New York, N.Y.)|April 11, 2015
Drug Development. Are trade secrets delaying biosimilars?W Nicholson Price, Arti K Rai
Biostatistics (Oxford, England)|November 20, 2019
Regulatory oversight, causal inference, and safe and effective health care machine learningAriel Dora Stern, W Nicholson Price
Nature Biotechnology|August 4, 2019
How logically impossible patents block biosimilarsW Nicholson Price, Arti K Rai
Nature Medicine|January 9, 2019
Privacy in the age of medical big dataW Nicholson Price, I Glenn Cohen
Journal of Law and the Biosciences|August 31, 2017
Promoting healthcare innovation on the demand sideRebecca S Eisenberg, W Nicholson Price
The American Journal of Bioethics : AJOB|November 6, 2023
Translating Commercial Health Data Privacy Ethics into ChangeKayte Spector-Bagdady, W Nicholson Price
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Michigan Law Review|December 15, 2017
Regulating Black-Box MedicineW Nicholson Price
The American Journal of Bioethics : AJOB|February 9, 2013
Legal implications of an ethical duty to search for genetic incidental findingsW Nicholson Price
Science Translational Medicine|December 14, 2018
Big data and black-box medical algorithmsW Nicholson Price
Nature Biotechnology|July 9, 2015
Will clinical trial data disclosure reduce incentives to develop new uses of drugs?W Nicholson Price, Timo Minssen
Science (New York, N.Y.)|April 11, 2015
Drug Development. Are trade secrets delaying biosimilars?W Nicholson Price, Arti K Rai
Biostatistics (Oxford, England)|November 20, 2019
Regulatory oversight, causal inference, and safe and effective health care machine learningAriel Dora Stern, W Nicholson Price
Nature Biotechnology|August 4, 2019
How logically impossible patents block biosimilarsW Nicholson Price, Arti K Rai
Nature Medicine|January 9, 2019
Privacy in the age of medical big dataW Nicholson Price, I Glenn Cohen
Journal of Law and the Biosciences|August 31, 2017
Promoting healthcare innovation on the demand sideRebecca S Eisenberg, W Nicholson Price
The American Journal of Bioethics : AJOB|November 6, 2023
Translating Commercial Health Data Privacy Ethics into ChangeKayte Spector-Bagdady, W Nicholson Price
Pageof 5